Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0KJ4U
|
||||
| Former ID |
DIB012347
|
||||
| Drug Name |
ACEA-1011
|
||||
| Synonyms |
Glystatin series member (1011), CoCensys
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cerebral infarction [ICD10:I63] | Terminated | [1] | ||
| Company |
Acea Pharmaceuticals Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H4ClF3N2O2
|
||||
| Canonical SMILES |
[nH]1c2c([nH]c(=O)c1=O)cc(C(F)(F)F)cc2Cl
|
||||
| CAS Number |
CAS 153504-72-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007916) | ||||
| REF 2 | NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. Brain Res. 1993 Jul 2;615(2):331-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.